Tu1161 Safety and Efficacy of Endoscopic Hybridapc for Management of Barrett's Esophagus

      Primary: To test the efficacy and safety of HybridAPC as a primary modality for ablation of Barrett's esophagus. Secondary: To test the efficacy of HybridAPC in patients with refractory Barrett's esophagus (patients who have failed treatment with radiofrequency ablation).
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Gastrointestinal Endoscopy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect